Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trialParesh Dandona, Bertrand Cariou, Chantal Mathieu et al.|The Lancet Diabetes & Endocrinology|2017Cited by 295
Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor CellsDominique Verhelle, Kyle Chan, Peter Schäfer et al.|Cancer Research|2007Cited by 232
Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.Laure Moutouh de Parseval, Kyle Chan, Helen Brady et al.|Blood|2005Cited by 3